Decheng Capital LLC Aura Biosciences, Inc. Transaction History
Decheng Capital LLC
- $573 Billion
- Q3 2025
A detailed history of Decheng Capital LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 515,555 shares of AURA stock, worth $2.85 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
515,555
Previous 515,555
-0.0%
Holding current value
$2.85 Million
Previous $3.23 Billion
1.28%
% of portfolio
0.56%
Previous 0.82%
Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
106Shares Held
52.1MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$38.3 Million66.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$28.2 Million1.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$27 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$25.5 Million1.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$24.2 Million0.81% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $162M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...